Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia.
Ai KuwaharaRyu SasakiMasanori FukushimaMasafumi HaraguchiSatoshi MiumaHisamitsu MiyaakiKazuhiko NakaoPublished in: JGH open : an open access journal of gastroenterology and hepatology (2020)
Shunt occlusion prior to lenvatinib administration prevented hyperammonemia and hepatic encephalopathy. Shunt occlusion may be an effective treatment option to administer molecular target agents in patients with portosystemic shunts.